MedPath

SuperStarch Study

Not Applicable
Conditions
Post-operative insulin resistance
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN45230380
Lead Sponsor
East Lancashire Healthcare Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Patients >18 years
2. Laparoscopic colorectal resection
3. Included in Enhanced Recovery Protocol
4. American Society of Anesthesiologists (ASA) Physical Status classification 1-3
5. Able to give consent

Exclusion Criteria

1. Non-English speaker
2. Pregnancy
3. Diagnosed diabetes mellitus (diet, drug or insulin controlled).
4. Diagnosed impaired glucose tolerance (fasting glucose in POAC >5.5 mmol/l and/or HbA1C>5.7%)
5. Decreased gastrointestinal motility (from medication or disease) or predisposition to reflux
6. Diagnosis of inflammatory bowel disease
7. Allergy to either preoperative carbohydrate drink

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in insulin resistance from baseline on postoperative day 1 (POD 1) measured by Homeostasis Model Assessment (HOMA), which utilises serial fasting blood glucose and insulin measurements.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath